Published

The enzymic dephosphorylation and oxidation of psilocybin and psilocin by mammalian tissue homogenates.

No abstract availability was recorded for this entry.

Open source BibTeX RIS

Bibliographic context

Journal: Biochemical pharmacology
Date: 1961-07-01
Source: PubMed
DOI: 10.1016/0006-2952(61)90124-1
PubMed: 13715852

Authors

HORITA A WEBER LJ

Watch author

Derived topics and classifications

psilocybin psilocin Pharmacology Other

Citation graph

0 referenced DOIs found in stored source metadata. 20 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Novel qNMR Method to Quantify Psilocybin and Psilocin in Psychedelic Mushrooms2025-11-25 Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis2025-01-01 In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin2024-04-29 Determination of psilocybin and psilocin content in multiple Psilocybe cubensis mushroom strains using liquid chromatography - tandem mass spectrometry2024-02-01 In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin2024-01-08 The Psilocin (4-hydroxy-N,N-dimethyltryptamine) and Bufotenine (5-hydroxy-N,N-dimethyltryptamine) Case: Ensuring the Correct Isomer has Been Identified2020-09-01 Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance2017-01-02 DNA-based taxonomic identification of basidiospores in hallucinogenic mushrooms cultivated in “grow-kits” seized by the police: LC-UV quali-quantitative determination of psilocybin and psilocin2016-06-01 Synthesis, hydrolysis and stability of psilocin glucuronide2014-04-01 Determination of psilocin, bufotenine, LSD and its metabolites in serum, plasma and urine by SPE-LC-MS/MS2013-05-01 A validated method for quantitation of psilocin in plasma by LC-MS/MS and study of stability2012-11-01 Determining the pharmacokinetics of psilocin in rat plasma using ultra-performance liquid chromatography coupled with a photodiode array detector after orally administering an extract of Gymnopilus spectabilis2011-09-01 Unifying electron transfer mechanism for psilocybin and psilocin2009-10-01 Direct detection of serum psilocin glucuronide by LC/MS and LC/MS/MS: time-courses of total and free (unconjugated) psilocin concentrations in serum specimens of a “magic mushroom” user2006-07-01 Development of a psilocin immunoassay for serum and blood samples2004-12-01 Optimized glucuronide hydrolysis for the detection of psilocin in human urine samples2003-11-01 Synthesis of a psilocin hapten and a protein-hapten conjugate2002-09-01 The Detection of Psilocin in Human Urine2001-05-01 11C-radiolabeling of hallucinogenic psilocin, a potential radioligand for studying the role of serotonin receptors in psychotic symptom formation1998-07-01 Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man1997-06-01

Related papers

Behavioural and pharmacological evaluation of the psilocybin analogue baeocystin in Wistar rats.Progress in neuro-psychopharmacology & biological psychiatry · 2025-07-13 Network Pharmacology-Guided Discovery of Fungal Autophagy Modulators for Tauopathies: Structural and Proteomic EvidencebioRxiv · 2026-07-27 The astrocytes in the prefrontal cortex contribute to the rapid antidepressant-like effects of psilocybin in the chronic restraint stress mouse modelProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2026-04-01 Differential effects of psilocybin and lisuride on serotonin and dopamine neuronal activity and behavior.Progress in neuro-psychopharmacology & biological psychiatry · 2025-10-02 Novel perspectives for glutamatergic strategies, psychedelics and antipsychotic augmentation in Treatment Resistant Depression: A narrative reviewClinical Neuropsychopharmacology and Addiction · 2025-09-24 Examining the potential of psilocybin and 5-MeO-DMT as therapeutics for traumatic brain injury.Progress in neuro-psychopharmacology & biological psychiatry · 2025-08-30 An overview of psilocybin, LSD, MDMA, and ketamine in revitalizing psychedelic-assisted therapy: Insights, limitations and future directions.Progress in neuro-psychopharmacology & biological psychiatry · 2025-08-30 The effect of low-dose psilocybin on brain neurotransmission and rat behavior.Progress in neuro-psychopharmacology & biological psychiatry · 2025-04-02